// App-Quantinova.ai

2579 : Prominin-1/CD133 Is Involved in the Lineage Decision As Well As a in the Sensitivity to Molecular Therapy in Ph+ Acute Lymphatic Leukemia.

Researchers

Presenter

  • Heike Pfeifer

Principal Investigators

  • Afsar Mian

  • Anja Vogel

  • Hubert Serve

  • Oliver G. Ottmann

  • Martin Ruthardt

Medical Centers

  • Department of Medicine, Hematology/Oncology, Goethe University of Frankfurt, Frankfurt, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Chronic Myelogenous Leukemia

  • Acute lymphoblastic leukemia

  • Colorectal Cancer

  • Solid malignancies

  • Preterm premature rupture of the membranes

Biomarkers

  • Breakpoint Cluster Region

  • Prominin 1

Drug/Treatment

  • Nilotinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved